Evidence map›Paper›PMID 40625759›Full record

ArticleInternational cancer conference journal2025

Complete recovery from pseudocirrhosis caused by chemotherapy for diffuse liver metastases of breast cancer.

Arimichi Kamata, Koji Hino, Kenichi Tazawa, Kimiko Kawai, Keiichi Arai, Atsushi Nakano

Abstract read
In one paragraph

Article in International cancer conference journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arimichi KamataDepartment of Breast Surgery, Tomei Atsugi Hospital, 232 Funako, Atsugi city, Kanagawa Japan.
Koji HinoDepartment of Breast Surgery, Tomei Atsugi Hospital, 232 Funako, Atsugi city, Kanagawa Japan.
Kenichi TazawaDepartment of Digestive Surgery, Tomei Atsugi Hospital, Atsugi, Japan.
Kimiko KawaiDepartment of Gastroenterology, Tomei Atsugi Hospital, Atsugi, Japan.
Keiichi AraiDepartment of Gastroenterology, Tomei Atsugi Hospital, Atsugi, Japan.
Atsushi NakanoDepartment of Gastroenterology, Tomei Atsugi Hospital, Atsugi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudocirrhosis refers to morphologic changes of the liver seen radiographically that mimic cirrhosis and arise in the setting of metastatic malignancy. Like true cirrhosis, pseudocirrhosis causes portal hypertension, which can lead to complications such as ascites and esophageal varices. We experienced a case of pseudocirrhosis that occurred during treatment for diffuse liver metastases from breast cancer. Pseudocirrhosis is often caused by diffuse hepatic cancer cell infiltration; however, in this case, it still occurred despite chemotherapy being effective. The shrinkage of liver metastases and subsequent scarring around them causes liver capsule regression, resulting in pseudocirrhotic changes. As a result of treatment for pseudocirrhosis, the once-atrophied liver regenerated and returned to its normal size after a year. Ascites and edema as portal pressure complications also disappeared. During this time, the liver metastases maintained a near-complete response. Cirrhosis accompanied by ascites is usually called "decompensated cirrhosis" and is considered difficult to improve; however, in pseudocirrhosis, the liver can regenerate and the patient can recover. Physicians must be fully aware of this disease.

Indexed as

Breast cancerChemotherapyLiver metastasesPseudocirrhosis

Identifiers

PMID40625759
PMCPMC12229408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.